174 related articles for article (PubMed ID: 36517565)
1. A pan-cancer analysis of the FAT1 in human tumors.
Wang Z; Lin K; Xiao H
Sci Rep; 2022 Dec; 12(1):21598. PubMed ID: 36517565
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell Lung Cancer.
Feng Z; Yin Y; Liu B; Zheng Y; Shi D; Zhang H; Qin J
Cancer Control; 2022; 29():10732748221076682. PubMed ID: 35212236
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of Atypical Cadherin FAT1 Promotes an Immunosuppressive Tumor Microenvironment
Irshad K; Srivastava C; Malik N; Arora M; Gupta Y; Goswami S; Sarkar C; Suri V; Mahajan S; Gupta DK; Suri A; Chattopadhyay P; Sinha S; Chosdol K
Front Immunol; 2022; 13():813888. PubMed ID: 35720420
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of FAT1 mutations to indicate the immune response in colorectal cancer patients.
Zhu W; Yang L; Gao Y; Zhou Y; Shi Y; Liu K; Yu R; Shao Y; Zhang W; Wu G; He J
Genomics; 2024 Mar; 116(2):110808. PubMed ID: 38364976
[TBL] [Abstract][Full Text] [Related]
5. A pan-cancer analysis of FAT atypical cadherin 4 (FAT4) in human tumors.
Mao W; Zhou J; Hu J; Zhao K; Fu Z; Wang J; Mao K
Front Public Health; 2022; 10():969070. PubMed ID: 36051999
[TBL] [Abstract][Full Text] [Related]
6. [Expression of FAT1 in Lung Adenocarcinoma and Its Relationship
with Immune Cell Infiltration].
Ding C; Zhao W; Huang H; Li Y; Zhang Z; Zhang R; Wang Y; Wu D; Chen C; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2024 Feb; 27(2):109-117. PubMed ID: 38453442
[TBL] [Abstract][Full Text] [Related]
7. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
8. Function and cancer genomics of FAT family genes (review).
Katoh M
Int J Oncol; 2012 Dec; 41(6):1913-8. PubMed ID: 23076869
[TBL] [Abstract][Full Text] [Related]
9. Association between FAT1 mutation and overall survival in patients with human papillomavirus-negative head and neck squamous cell carcinoma.
Kim KT; Kim BS; Kim JH
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E2021-9. PubMed ID: 26876381
[TBL] [Abstract][Full Text] [Related]
10. Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic target: A bulk omics research and single cell sequencing validation.
Qin Y; Yang J; Liang C; Liu J; Deng Z; Yan B; Fu Y; Luo Y; Li X; Wei X; Li W
Front Immunol; 2022; 13():994828. PubMed ID: 36405728
[TBL] [Abstract][Full Text] [Related]
11. Favorable immune checkpoint inhibitor outcome of patients with melanoma and NSCLC harboring FAT1 mutations.
Zhang W; Tang Y; Guo Y; Kong Y; Shi F; Sheng C; Wang S; Wang Q
NPJ Precis Oncol; 2022 Jun; 6(1):46. PubMed ID: 35739249
[TBL] [Abstract][Full Text] [Related]
12. The Proteomic Landscape of Growth Factor Signaling Networks Associated with
Chen Z; Zhang C; Chen J; Wang D; Tu J; Van Waes C; Saba NF; Chen ZG; Chen Z
Cancer Res; 2021 Sep; 81(17):4402-4416. PubMed ID: 34167951
[TBL] [Abstract][Full Text] [Related]
13. NFкB is a critical transcriptional regulator of atypical cadherin FAT1 in glioma.
Srivastava C; Irshad K; Gupta Y; Sarkar C; Suri A; Chattopadhyay P; Sinha S; Chosdol K
BMC Cancer; 2020 Jan; 20(1):62. PubMed ID: 31992226
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation.
Qin Y; Pan L; Qin T; Ruan H; Zhang Y; Zhang Y; Li J; Yang J; Li W
Front Immunol; 2022; 13():998266. PubMed ID: 36248785
[TBL] [Abstract][Full Text] [Related]
15. Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation.
Morris LG; Kaufman AM; Gong Y; Ramaswami D; Walsh LA; Turcan Ş; Eng S; Kannan K; Zou Y; Peng L; Banuchi VE; Paty P; Zeng Z; Vakiani E; Solit D; Singh B; Ganly I; Liau L; Cloughesy TC; Mischel PS; Mellinghoff IK; Chan TA
Nat Genet; 2013 Mar; 45(3):253-61. PubMed ID: 23354438
[TBL] [Abstract][Full Text] [Related]
16. The diverse functions of FAT1 in cancer progression: good, bad, or ugly?
Chen ZG; Saba NF; Teng Y
J Exp Clin Cancer Res; 2022 Aug; 41(1):248. PubMed ID: 35965328
[TBL] [Abstract][Full Text] [Related]
17. FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival.
Lin SC; Lin LH; Yu SY; Kao SY; Chang KW; Cheng HW; Liu CJ
Carcinogenesis; 2018 Dec; 39(11):1320-1330. PubMed ID: 30102337
[TBL] [Abstract][Full Text] [Related]
18. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
19. Role of Fat1 in cell-cell contact formation of podocytes in puromycin aminonucleoside nephrosis and neonatal kidney.
Yaoita E; Kurihara H; Yoshida Y; Inoue T; Matsuki A; Sakai T; Yamamoto T
Kidney Int; 2005 Aug; 68(2):542-51. PubMed ID: 16014031
[TBL] [Abstract][Full Text] [Related]
20. FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer.
Hu X; Zhai Y; Kong P; Cui H; Yan T; Yang J; Qian Y; Ma Y; Wang F; Li H; Cheng C; Zhang L; Jia Z; Li Y; Yang B; Xu E; Wang J; Yang J; Bi Y; Chang L; Wang Y; Zhang Y; Song B; Li G; Shi R; Liu J; Zhang M; Cheng X; Cui Y
Cancer Lett; 2017 Jul; 397():83-93. PubMed ID: 28366557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]